Thrivent Financial for Lutherans’s Liberty Media Corporation Series C Common Stock FWONK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$601K Hold
6,320
– – ﹤0.01% 2238
2026
Q1
$538K Sell
6,320
-453
-7% -$39.6K ﹤0.01% 2192
2025
Q4
$668K Sell
6,773
-552
-8% -$54.2K ﹤0.01% 2142
2025
Q3
$765K Sell
7,325
-3,262
-31% -$331K ﹤0.01% 1918
2025
Q2
$1.11M Buy
+10,587
New +$984K ﹤0.01% 1728
2017
Q2
– Sell
-17
Closed -$1K – 2047
2017
Q1
$1K Hold
17
– – ﹤0.01% 1988
2016
Q4
$1K Hold
17
– – ﹤0.01% 1976
2016
Q3
$0 Hold
17
– – ﹤0.01% 2013
2016
Q2
$0 Buy
+17
New +$331 ﹤0.01% 2026

Other funds holding FWONK

Thrivent Financial for Lutherans's FWONK Position: Q2 2026 in Review

Thrivent Financial for Lutherans held its Liberty Media Corporation Series C Common Stock (FWONK) position steady in Q2 2026 at 6,320 shares worth $601K. The position accounts for ﹤0.01% of the portfolio, ranked #2238.

Thrivent Financial for Lutherans first reported a position in FWONK in Q2 2016 and has held it in 9 quarters since. The position peaked at $1.11M in Q2 2025. 632 funds tracked by Wall St. Rank hold FWONK as of Q2 2026.

  • Thrivent Financial for Lutherans held 6,320 shares of Liberty Media Corporation Series C Common Stock worth $601K as of Q2 2026.
  • Thrivent Financial for Lutherans left its Liberty Media Corporation Series C Common Stock share count unchanged in Q2 2026.
  • Liberty Media Corporation Series C Common Stock made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #2238 holding.
  • Thrivent Financial for Lutherans first reported a position in Liberty Media Corporation Series C Common Stock in Q2 2016 and has held it in 9 quarters since.
  • Thrivent Financial for Lutherans's Liberty Media Corporation Series C Common Stock position peaked at $1.11M in Q2 2025.
  • 632 funds tracked by Wall St. Rank held Liberty Media Corporation Series C Common Stock as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.